Survival Rates Using Individualized Bioselection Treatment Methods in Patients With Advanced Laryngeal Cancer - Wikidata - awgldk - TriplyDB

Survival Rates Using Individualized Bioselection Treatment Methods in Patients With Advanced Laryngeal Cancer

Survival Rates Using Individualized Bioselection Treatment Methods in Patients With Advanced Laryngeal Cancer

http://www.wikidata.org/entity/Q33711438

about

Survival Outcomes in Patients with T2N0M0 (Stage II) Squamous Cell Carcinoma of the Larynx.Individualized outcome prognostication for patients with laryngeal cancer.

P2860

Q38728154-8DD7C621-67F1-4B3B-95FF-9E3C7DFF99F6 Q48350346-3473A811-BD48-41FC-9F63-88F6B4E83DA7

P2860

Survival Rates Using Individualized Bioselection Treatment Methods in Patients With Advanced Laryngeal Cancer

http://www.wikidata.org/entity/Q33711438

description

2017 nî lūn-bûn

@nan

2017 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Survival Rates Using Individua ...... With Advanced Laryngeal Cancer

@ast

Survival Rates Using Individua ...... With Advanced Laryngeal Cancer

@en

type

label

Survival Rates Using Individua ...... With Advanced Laryngeal Cancer

@ast

Survival Rates Using Individua ...... With Advanced Laryngeal Cancer

@en

prefLabel

Survival Rates Using Individua ...... With Advanced Laryngeal Cancer

@ast

Survival Rates Using Individua ...... With Advanced Laryngeal Cancer

@en

P1433

Q33711438-D7D2398A-D5ED-434D-9CE2-9AB4A1D866E4

P1476

Q33711438-AEDAA260-DDD9-4A50-AA3D-A65150E47851

P2093

Q33711438-1A71453A-7938-4E87-9EB5-B01E31B0A4DC

Q33711438-266F2624-4E19-453D-8CEE-63C609914B36

Q33711438-26C5EA6C-4211-4154-8B5C-20F9E89DC7CE

Q33711438-586951B8-600C-4D02-AE4C-5BE440CFC82D

Q33711438-5C6557BD-190E-4892-AF98-2CC24FB80B8A

Q33711438-6F73DDB7-9965-4C62-82CD-D91D01E6F31A

Q33711438-8D042027-3D02-40AD-87E3-E1CDC0866723

Q33711438-8F2E48DA-5F8C-4361-B666-D805557E080B

Q33711438-8F6EBF23-EB03-450C-8B45-D4914D94FAA7

Q33711438-937D801F-8DB1-4353-BD04-4F66C8CC5A73

P2860

Q33711438-0348F277-809B-4938-BA16-FEAC4297A8A9

Q33711438-06BC8B01-AAAA-4AC2-89EE-8C3C0B754E8D

Q33711438-0B0AD349-325D-4A78-834A-86A7BB9332E7

Q33711438-0F61B76C-A89A-4C8D-A9EF-F437D54029A2

Q33711438-11E45D8C-91ED-41AC-A726-E9A921A3E175

Q33711438-1646C68E-5B89-49AE-8E3C-9A5D08D18566

Q33711438-1AA2F2E1-F641-4AA4-8827-20D7DACBD3D0

Q33711438-27B0BDC9-F217-4E91-A9EC-2D466A84CC27

Q33711438-361A0F99-AA4E-46D5-B9B7-49378DFAD561

Q33711438-3EF6D1A2-149C-40AE-A293-855E22CE426D

P304

Q33711438-0FA25177-AEAB-400E-A575-CFC40B022139

P31

Q33711438-3CEF6A88-EAA5-4C79-9A8D-03B23BEEEA2E

P356

Q33711438-175DAA19-9F99-46B4-BE98-8E74E4A871C0

P407

Q33711438-B474F781-D983-4B51-8FC4-2ED4A885CB5B

P433

Q33711438-63486E38-6642-4695-B302-2F5B00251657

P478

Q33711438-0FD07EB6-8C09-43FD-9905-40C2EE032A83

P50

Q33711438-767AB5E6-0A5D-4992-AA2C-5D5FD8B8093F

P577

Q33711438-FDDEF73A-10CA-4DAF-A650-5113FAC90356

P698

Q33711438-421AEA2A-68D1-43F1-9306-604104E2B3B9

P932

Q33711438-45312EC1-8231-4830-BEC2-6F2169B7C8E9

P356

JAMAOTO.2016.3669

P1433

JAMA Otolaryngology–Head & Neck Surgery

P1476

Survival Rates Using Individua ...... With Advanced Laryngeal Cancer

@en

P2093

Carol R Bradford

http://www.w3.org/2001/XMLSchema#string

Douglas B Chepeha

http://www.w3.org/2001/XMLSchema#string

Emily Bellile

http://www.w3.org/2001/XMLSchema#string

Francis P Worden

http://www.w3.org/2001/XMLSchema#string

Gregory T Wolf

http://www.w3.org/2001/XMLSchema#string

Jeffery Moyer

http://www.w3.org/2001/XMLSchema#string

Jeremy M G Taylor

http://www.w3.org/2001/XMLSchema#string

Lisa Peterson

http://www.w3.org/2001/XMLSchema#string

Mark E Prince

http://www.w3.org/2001/XMLSchema#string

Norman D Hogikyan

http://www.w3.org/2001/XMLSchema#string

P2860

Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.

Accelerated repopulation as a cause of radiation treatment failure in non-small cell lung cancer: review of current data and future clinical strategies.

Evidence-based review of treatment options for patients with glottic cancer.

Transoral laser microsurgery for advanced laryngeal cancer.

Endoscopic laser surgery of early glottic cancer: involvement of the anterior commissure.

Chemotherapy alone for organ preservation in advanced laryngeal cancer.

Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer.

Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial.

Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer.

Circulating CD4-positive lymphocyte levels as predictor of response to induction chemotherapy in patients with advanced laryngeal cancer

P304

355-366

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMAOTO.2016.3669

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

143

http://www.w3.org/2001/XMLSchema#string

P50

Avraham Eisbruch

P577

2017-02-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28152117

http://www.w3.org/2001/XMLSchema#string

P932

5439146

http://www.w3.org/2001/XMLSchema#string